Sara Rogers, PharmD, BCPS
Clinical Assistant Professor
Texas A&M University
Presentation: Deprescribing to Improve Patient Care & Quality of Life
Sara Rogers serves as Clinical Assistant Professor of Precision Medicine and Ambulatory Care at Irma Lerma Rangel College of Pharmacy, Texas A&M University and Clinical Specialist at Texas A&M Physicians Clinic. She co-founded the American Society of Pharmacovigilance, where she led the Society’s clinical, research and educational initiatives. Rogers co-led the formation of the Pharmacogenomics Access and Reimbursement Coalition and collaboratively developed the Coalition’s research agenda to understand the payment and policy landscape for pharmacogenetics testing and its role in disparities in patient access. Rogers serves as an organizational member of the NIH National Human Genomics Research Institute Inter-Society Coordinating Committee and develops educational resources to help practitioners navigate coverage for pharmacogenetics testing. Her research track record reveals a long-standing goal of informing policy and practice. Dr. Rogers has served as co-investigator for a pilot study to identify ethical values and priorities related to pharmacogenomics. Her research focuses extensively on patient access to and reimbursement for pharmacogenetics testing. Rogers co-led the formation of the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, a public-private multidisciplinary initiative to develop consensus-based industry standards for pharmacogenetics testing.
Prior to serving in these roles, Rogers was an Ambulatory Treatment Center pharmacist at MD Anderson Cancer Center where she led team-based research projects to optimize workflow and screening protocols throughout the division of pharmacy.
Sara Rogers does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).